viernes, 24 de enero de 2025
SKIN & INFLAMMATORY CONDITIONS
SKIN & INFLAMMATORY CONDITIONS
Key Target for Seborrheic Dermatitis Highlighted
Inflammation Now the Key Target for Seborrheic Dermatitis
Ted Bosworth
https://www.medscape.com/viewarticle/inflammation-now-key-target-seborrheic-dermatitis-2025a100005x?ecd=mkm_ret_250124_mscpmrk_allergy_top-content_etid7181790&uac=148436CN&impID=7181790
January 06, 2025
Allergic Contact Dermatitis: New Culprits
Allergic Contact Dermatitis: New Culprits
Stéphanie Lavaud
https://www.medscape.com/viewarticle/allergic-contact-dermatitis-new-culprits-2024a1000ok0?ecd=mkm_ret_250124_mscpmrk_allergy_top-content_etid7181790&uac=148436CN&impID=7181790
Topical Ruxolitinib: Practice Essential
ruxolitinib topical (Rx)
https://reference.medscape.com/drug/opzelura-ruxolitinib-topical-4000177?ecd=mkm_ret_250124_mscpmrk_allergy_top-content_etid7181790&uac=148436CN&impID=7181790
Long-Term Budesonide Shows Sustained Efficacy in EoE
Long-Term Budesonide Shows Sustained Efficacy in Eosinophilic Esophagitis
Edited by Vinod Rane
https://www.medscape.com/viewarticle/long-term-budesonide-shows-sustained-efficacy-eosinophilic-2025a10000jk?ecd=mkm_ret_250124_mscpmrk_allergy_top-content_etid7181790&uac=148436CN&impID=7181790
January 10, 2025
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario